A BILL 
To improve kidney disease research, prevention, surveillance, 
and treatment in minority populations and rural and 
underserved communities, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Coordination, Account-
4
ability, Research, and Equity for All Kidneys Act of 2021’’ 
5
or the ‘‘CARE for All Kidneys Act of 2021’’. 
6
00:48 Jul 20, 2021
H3893
2 
•HR 3893 IH
SEC. 2. KIDNEY DISEASE RESEARCH IN MINORITY POPU-
1
LATIONS AND RURAL AND UNDERSERVED 
2
COMMUNITIES. 
3
(a) IN GENERAL.—The Director of the National In-
4
stitutes of Health shall expand, intensify, and support on-
5
going research and other activities with respect to kidney 
6
disease in minority populations and rural and underserved 
7
communities. 
8
(b) CONSULTATION.—The Director of the National 
9
Institutes of Health shall carry out subsection (a) in con-
10
sultation with the Administrator of the Centers for Medi-
11
care & Medicaid Services, working with personnel of the 
12
Centers who are responsible for chronic care management 
13
activities and have expertise in kidney care. 
14
(c) RESEARCH.— 
15
(1) DESCRIPTION.—Research under subsection 
16
(a) shall include investigation into— 
17
(A) the causes of kidney disease, including 
18
socioeconomic, geographic, clinical, environ-
19
mental, genetic, racial, ethnic, and other factors 
20
that may contribute to increased rates of kidney 
21
disease in minority populations and rural and 
22
underserved communities; and 
23
(B) the causes of increased incidence of 
24
kidney disease complications in minority popu-
25
lations and rural and underserved communities, 
26
00:48 Jul 20, 2021
H3893
3 
•HR 3893 IH
and possible clinical and nonclinical (such as 
1
food security, housing, and access to coverage) 
2
interventions to decrease such incidence. 
3
(2) INCLUSION
OF
PARTICIPANTS.—In con-
4
ducting and supporting research described in sub-
5
section (a), the Director of the National Institutes of 
6
Health shall seek to include participants from mi-
7
nority populations and rural and underserved com-
8
munities as study subjects in clinical trials. 
9
(d) REPORT.— 
10
(1) IN
GENERAL.—Not later than 6 months 
11
after the date of enactment of this section, the Sec-
12
retary of Health and Human Services shall prepare 
13
and submit to the Congress a report on Federal re-
14
search and public health activities with respect to 
15
kidney disease in minority populations and rural and 
16
underserved communities. 
17
(2) CONTENTS.—The report under paragraph 
18
(1) shall at minimum address each of the following: 
19
(A) Research on kidney disease in minority 
20
populations and rural and underserved commu-
21
nities, including such research on— 
22
(i) socioeconomic, geographic, clinical, 
23
environmental, genetic, racial, ethnic, and 
24
other factors (such as food security, hous-
25
00:48 Jul 20, 2021
H3893
4 
•HR 3893 IH
ing, and access to coverage) that may con-
1
tribute to increased rates of kidney disease 
2
in minority populations and rural and un-
3
derserved communities; and 
4
(ii) 
prevention 
and 
complications 
5
among individuals within these populations 
6
and communities who have already devel-
7
oped kidney disease. 
8
(B) Surveillance and data collection on 
9
kidney disease in minority populations and 
10
rural and underserved communities, including 
11
with respect to— 
12
(i) efforts to better determine the 
13
prevalence of kidney disease among Black, 
14
Hispanic/Latino, and Asian-American and 
15
Pacific Islander subgroups; and 
16
(ii) efforts to coordinate data collec-
17
tion on the American Indian population. 
18
(C) Community-based interventions to ad-
19
dress kidney disease targeting minority popu-
20
lations and rural and underserved communities, 
21
including— 
22
(i) the evidence base for such inter-
23
ventions; 
24
00:48 Jul 20, 2021
H3893
5 
•HR 3893 IH
(ii) the cultural appropriateness of 
1
such interventions; and 
2
(iii) efforts to educate the public on 
3
the causes of kidney disease, the impor-
4
tance of maintaining kidney health, and 
5
actions individuals can take to avoid kid-
6
ney disease. 
7
(D) Education and training programs for 
8
health 
professionals 
(including 
community 
9
health workers) on the prevention and manage-
10
ment of kidney disease and its related complica-
11
tions that is supported by the Health Resources 
12
and Services Administration, including such 
13
programs supported by the Bureau of Health 
14
Workforce, the Bureau of Primary Health Care, 
15
and the Healthcare Systems Bureau. 
16
SEC. 3. KIDNEY DISEASE ACTION PLAN. 
17
(a) IN
GENERAL.—The Assistant Secretary for 
18
Health of the Department of Health and Human Services 
19
shall conduct, support, and expand public health strate-
20
gies, prevention, diagnosis, surveillance, and public and 
21
professional awareness activities regarding kidney disease. 
22
(b) NATIONAL ACTION PLAN.— 
23
(1) DEVELOPMENT.—Not later than 2 years 
24
after the date of the enactment of this Act, the As-
25
00:48 Jul 20, 2021
H3893
6 
•HR 3893 IH
sistant Secretary for Health of the Department of 
1
Health and Human Services shall develop a national 
2
action plan to address kidney disease in the United 
3
States with participation from patients, caregivers, 
4
health professionals, patient advocacy organizations, 
5
researchers, providers, public health professionals, 
6
and other stakeholders. 
7
(2) CONTENTS.—At a minimum, such plan 
8
shall include recommendations for— 
9
(A) public health interventions for the pur-
10
pose of implementation of the national plan; 
11
(B) biomedical, health services, and public 
12
health research on kidney disease; and 
13
(C) inclusion of kidney disease in the 
14
health data collections of all Federal agencies. 
15
(c) KIDNEY DISEASE PREVENTION PROGRAMS.—At 
16
the conclusion of the development of the national action 
17
plan under subsection (b), the Director of the National 
18
Institute of Diabetes and Digestive and Kidney Disease 
19
shall conduct public education and awareness activities 
20
with patient and professional organizations to stimulate 
21
earlier diagnosis and improve patient outcomes from treat-
22
ment of kidney disease. To the extent known and relevant, 
23
such public education and awareness activities shall reflect 
24
differences in kidney disease by cause (such as hyper-
25
00:48 Jul 20, 2021
H3893
7 
•HR 3893 IH
tension, diabetes, and polycystic kidney disease) and in-
1
clude a focus on outreach to undiagnosed and, as appro-
2
priate, minority populations and rural and underserved 
3
communities. 
4
(d) GRANTS FOR REDUCING BURDEN OF KIDNEY 
5
DISEASE.—Beginning not later than 2 years after the 
6
date of enactment of this Act, the Director of the Centers 
7
for Disease Control and Prevention shall supplement and 
8
expand upon the activities of the National Institute of Di-
9
abetes and Digestive and Kidney Disease by making 
10
grants to nonprofit organizations, State and local jurisdic-
11
tions, and Indian Tribes for the purpose of reducing the 
12
burden of kidney disease, especially in disproportionately 
13
impacted communities, through public health interventions 
14
and related activities. 
15
(e) DEVELOPMENT OF BEST PRACTICES FOR DIAG-
16
NOSIS AND MANAGEMENT OF KIDNEY DISEASE.—Begin-
17
ning not later than 2 years after the date of enactment 
18
of this Act, the Assistant Secretary for Health of the De-
19
partment of Health and Human Services shall— 
20
(1) in coordination with the Centers for Disease 
21
Control and Prevention, the Indian Health Service, 
22
the Health Resources and Services Administration, 
23
the Department of Veterans Affairs, dialysis pro-
24
viders, nephrologists, medical societies, and nursing 
25
00:48 Jul 20, 2021
H3893
8 
•HR 3893 IH
groups, develop pilot programs to demonstrate best 
1
practices for the diagnosis and management of kid-
2
ney disease; and 
3
(2) design such pilot programs and best prac-
4
tices for use by— 
5
(A) general practitioners, family physi-
6
cians, internal medicine practitioners, nurse 
7
practitioners, and physician assistants in pri-
8
vate practice; and 
9
(B) Federally qualified health centers, In-
10
dian reservations, prisons, community health 
11
centers, and other primary care settings. 
12
(f) DATA COLLECTION.—Not later than 180 days 
13
after the date of enactment of this Act, the Director of 
14
the National Institute of Diabetes and Digestive and Kid-
15
ney Disease and the Director of the Centers for Disease 
16
Control and Prevention, acting jointly, shall assess the 
17
depth and quality of information on kidney disease that 
18
is collected in surveys and population studies conducted 
19
by the Centers for Disease Control and Prevention, includ-
20
ing whether there are additional opportunities for informa-
21
tion to be collected in the National Health and Nutrition 
22
Examination Survey, the National Health Interview Sur-
23
vey, and the Behavioral Risk Factors Surveillance System 
24
surveys. The Director of the National Institute of Diabetes 
25
00:48 Jul 20, 2021
H3893
9 
•HR 3893 IH
and Digestive and Kidney Disease shall include the results 
1
of such assessment in the national action plan under sub-
2
section (b). 
3
(g) AUTHORIZATION
OF APPROPRIATIONS.—There 
4
are authorized to be appropriated to carry out this sec-
5
tion— 
6
(1) $1,000,000 for fiscal year 2022; 
7
(2) $1,000,000 for fiscal year 2023; 
8
(3) $1,000,000 for fiscal year 2024; 
9
(4) $1,000,000 for fiscal year 2025; and 
10
(5) $1,000,000 for fiscal year 2026. 
11
SEC. 4. REPORT ON END-STAGE RENAL DISEASE (ESRD) 
12
TREATMENT CHOICES (ETC) MODEL. 
13
The Assistant Secretary for Health of the Depart-
14
ment of Health and Human Services shall— 
15
(1) annually provide to the Congress a report 
16
on how the end-stage renal disease treatment choices 
17
model has affected minority populations and rural 
18
and underserved communities; and 
19
(2) in each such report, include the number and 
20
percentage of people in home dialysis categorized by 
21
race, ethnicity, gender, geographic location, and age. 
22
00:48 Jul 20, 2021
H3893
10 
•HR 3893 IH
SEC. 5. INCREASING KIDNEY TRANSPLANTS IN MINORITY, 
1
RURAL, AND UNDERSERVED COMMUNITIES. 
2
(a) IN GENERAL.—The Director of the National In-
3
stitutes of Health shall expand, intensify, and support on-
4
going research and other activities with respect to kidney 
5
transplants in minority populations and rural and under-
6
served communities. 
7
(b) CONSULTATION.—The Director of the National 
8
Institutes of Health shall carry out this section in con-
9
sultation with the Administrator of the Centers for Medi-
10
care & Medicaid Services, working with personnel of the 
11
Centers who are responsible for chronic care management 
12
activities and have expertise in kidney care. 
13
(c) RESEARCH.—Research under subsection (a) shall 
14
include investigation into— 
15
(1) the causes of lower rates of kidney trans-
16
plants in minority, rural, and underserved commu-
17
nities, including socioeconomic, geographic, clinical, 
18
environmental, genetic, racial, ethnic, and other fac-
19
tors that may contribute to lower rates of kidney 
20
transplants in minority populations and rural and 
21
underserved communities; and 
22
(2) possible interventions to increase kidney 
23
transplants. 
24
(d) REPORT; COMPREHENSIVE PLAN.— 
25
00:48 Jul 20, 2021
H3893
11 
•HR 3893 IH
(1) IN GENERAL.—The Secretary of Health and 
1
Human Services shall— 
2
(A) prepare and submit to the Congress, 
3
not later than 6 months after the date of enact-
4
ment of this section, a report on Federal re-
5
search and public health activities with respect 
6
to kidney transplants as a treatment for end- 
7
stage renal disease in minority populations and 
8
rural and underserved communities; and 
9
(B) develop and submit to the Congress, 
10
not later than 1 year after the date of enact-
11
ment of this section, an effective and com-
12
prehensive Federal plan (including all appro-
13
priate Federal health programs) to increase the 
14
number of kidney transplants in minority popu-
15
lations and rural and underserved communities. 
16
(2) CONTENTS.—The report under paragraph 
17
(1)(A) shall at minimum address each of the fol-
18
lowing: 
19
(A) Research on kidney transplants in mi-
20
nority populations and rural and underserved 
21
communities, including such research on finan-
22
cial, insurance coverage, genetic, behavioral, 
23
and environmental factors. 
24
00:48 Jul 20, 2021
H3893
12 
•HR 3893 IH
(B) Surveillance and data collection on 
1
kidney transplants in minority populations and 
2
rural and underserved communities, including 
3
with respect to— 
4
(i) efforts to increase kidney trans-
5
plants 
among 
Black, 
Hispanic/Latino, 
6
Asian-American, and Pacific Islander sub-
7
groups with end-stage renal disease; and 
8
(ii) efforts to increase kidney trans-
9
plants in the American Indian population. 
10
(C) Community-based efforts to increase 
11
kidney transplants targeting minority popu-
12
lations and rural and underserved communities, 
13
including— 
14
(i) the evidence base for such in-
15
creases; 
16
(ii) the cultural appropriateness of 
17
such increases; and 
18
(iii) efforts to educate the public on 
19
the kidney transplants. 
20
(D) Education and training programs for 
21
health 
professionals 
(including 
community 
22
health workers) on kidney transplants that are 
23
supported by the Health Resources and Serv-
24
ices Administration, including such programs 
25
00:48 Jul 20, 2021
H3893
13 
•HR 3893 IH
supported by the Bureau of Health Workforce, 
1
the Bureau of Primary Health Care, and the 
2
Healthcare Systems Bureau. 
3
SEC. 6. ENVIRONMENTAL AND OCCUPATIONAL HEALTH 
4
PROGRAMS. 
5
The Director of the Centers for Disease Control and 
6
Prevention shall— 
7
(1) support research into the environmental and 
8
occupational causes and biological mechanisms that 
9
contribute to kidney disease; and 
10
(2) develop and disseminate public health inter-
11
ventions that will lessen the impact of environmental 
12
and occupational causes of kidney disease. 
13
SEC. 7. UNDERSTANDING THE TREATMENT PATTERNS AS-
14
SOCIATED 
WITH 
PROVIDING 
CARE 
AND 
15
TREATMENT OF KIDNEY FAILURE IN MINOR-
16
ITY POPULATIONS AND RURAL AND UNDER-
17
SERVED COMMUNITIES. 
18
(a) STUDY.—The Secretary of Health and Human 
19
Services (in this section referred to as the ‘‘Secretary’’) 
20
shall conduct a study on treatment patterns associated 
21
with providing care, under the Medicare program under 
22
title XVIII of the Social Security Act (42 U.S.C. 1395 
23
et seq.), the Medicaid program under title XIX of such 
24
Act (42 U.S.C. 1396 et seq.), and through private health 
25
00:48 Jul 20, 2021
H3893
14 
•HR 3893 IH
insurance, to minority populations, and rural and under-
1
served communities, that are disproportionately affected 
2
by kidney failure. 
3
(b) REPORT.—Not later than 1 year after the date 
4
of the enactment of this Act, the Secretary shall submit 
5
to the Congress a report on the study conducted under 
6
subsection (a), together with such recommendations as the 
7
Secretary determines to be appropriate. 
8
SEC. 8. IMPROVING ACCESS IN UNDERSERVED AREAS. 
9
(a) DEFINITION OF PRIMARY CARE SERVICES.—Sec-
10
tion 331(a)(3)(D) of the Public Health Service Act (42 
11
U.S.C. 254d(a)(3)(D)) is amended by inserting ‘‘renal di-
12
alysis,’’ after ‘‘dentistry,’’. 
13
(b) NATIONAL HEALTH SERVICE CORPS SCHOLAR-
14
SHIP PROGRAM.—Section 338A(a)(2) of the Public Health 
15
Service Act (42 U.S.C. 254l(a)(2)) is amended by insert-
16
ing ‘‘, which may include nephrology health professionals’’ 
17
before the period at the end. 
18
(c) NATIONAL HEALTH SERVICE CORPS LOAN RE-
19
PAYMENT PROGRAM.—Section 338B(a)(2) of the Public 
20
Health Service Act (42 U.S.C. 254l–1(a)(2)) is amended 
21
by inserting ‘‘, which may include nephrology health pro-
22
fessionals’’ before the period at the end. 
23
Æ 
00:48 Jul 20, 2021
H3893
